R-IDARAM plus intrathecal chemotherapy

DRUG2 trials

Sponsors

Navy General Hospital, Beijing

Conditions

Primary Central Nervous System Lymphoma

Phase 2

Treatment of PCNSL With R-IDARAM and Intrathecal Immunochemotherapy

RecruitingNCT02657785

Navy General Hospital, BeijingPrimary Central Nervous System Lymphoma

Start: 2010-09-30End: 2030-12-31Target: 100Updated: 2020-09-09

Therapeutic Effects of R-IDARAM and Intrathecal Immunochemotherapy on Elderly Patients With PCNSL

RecruitingNCT02836158

Navy General Hospital, BeijingPrimary Central Nervous System Lymphoma

Start: 2010-09-30End: 2030-12-31Target: 100Updated: 2020-09-09